Suppr超能文献

突变和其他 ALS/FTD 相关基因患者中的错误折叠 SOD1 包含体。

Misfolded SOD1 inclusions in patients with mutations in and other ALS/FTD-associated genes.

机构信息

Medical Biosciences, Umeå University, Umeå, Sweden.

Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.

出版信息

J Neurol Neurosurg Psychiatry. 2019 Aug;90(8):861-869. doi: 10.1136/jnnp-2018-319386. Epub 2019 Apr 16.

Abstract

OBJECTIVE

A hallmark of amyotrophic lateral sclerosis (ALS) caused by mutations in () are inclusions containing SOD1 in motor neurons. Here, we searched for SOD1-positive inclusions in 29 patients carrying ALS-linked mutations in six other genes.

METHODS

A panel of antibodies that specifically recognise misfolded SOD1 species were used for immunohistochemical investigations of autopsy tissue.

RESULTS

The 18 patients with hexanucleotide-repeat-expansions in had inclusions of misfolded wild type (WT) SOD1 in spinal motor neurons. Similar inclusions were occasionally observed in medulla oblongata and in the motor cortex and frontal lobe. Patients with mutations in or , carried similar SOD1 inclusions. Minute amounts of misSOD1 inclusions were detected in 2 of 20 patients deceased from non-neurological causes and in 4 of 10 patients with other neurodegenerative diseases. Comparison was made with 17 patients with 9 different mutations. Morphologically, the inclusions in patients with mutations in and resembled inclusions in patients carrying the wildtype-like mutation, whereas patients carrying unstable mutations (A4V, V5M, D76Y, D83G, D101G, G114A, G127X, L144F) had larger skein-like SOD1-positive inclusions.

CONCLUSIONS AND RELEVANCE

Abundant inclusions containing misfolded SOD1 are found in spinal and cortical motor neurons in patients carrying mutations in six ALS-causing genes other than . This suggests that misfolding of SOD1 can be part of a common downstream event that may be pathogenic. The new anti-SOD1 therapeutics in development may have applications for a broader range of patients.

摘要

目的

由 () 突变引起的肌萎缩侧索硬化症(ALS)的一个标志是运动神经元中含有 SOD1 的包涵体。在这里,我们在另外六个基因携带 ALS 相关突变的 29 名患者中搜索了 SOD1 阳性包涵体。

方法

使用一组专门识别错误折叠 SOD1 物种的抗体,对尸检组织进行免疫组织化学研究。

结果

18 名携带 中六核苷酸重复扩展的患者的脊髓运动神经元中存在错误折叠野生型(WT)SOD1 的包涵体。在延髓和运动皮层以及额叶中偶尔也观察到类似的包涵体。携带 或 突变的患者携带类似的 SOD1 包涵体。在因非神经原因死亡的 20 名患者中的 2 名和其他神经退行性疾病的 10 名患者中的 4 名中,检测到微量的 misSOD1 包涵体。与携带 9 种不同 突变的 17 名患者相比。在携带 和 突变的患者中,包涵体的形态类似于携带野生型样 突变的患者,而携带不稳定 突变(A4V、V5M、D76Y、D83G、D101G、G114A、G127X、L144F)的患者具有更大的绳结样 SOD1 阳性包涵体。

结论和相关性

在携带除 以外的六个导致 ALS 的基因突变的患者的脊髓和皮质运动神经元中发现了大量含有错误折叠 SOD1 的包涵体。这表明 SOD1 的错误折叠可能是一种共同的下游事件的一部分,可能具有致病性。正在开发的新型抗 SOD1 治疗药物可能适用于更广泛的患者群体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1496/6691870/d353fccc4f9d/jnnp-2018-319386f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验